HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity ; volume:10 ; number:1 ; day:23 ; month:9 ; year:2013 ; pages:1-19 ; date:12.2013
Retrovirology ; 10, Heft 1 (23.9.2013), 1-19, 12.2013
- Urheber
-
van den Kerkhof, Tom L G M.
- Beteiligte Personen und Organisationen
-
Feenstra, K Anton
Euler, Zelda
van Gils, Marit J.
Rijsdijk, Linda W E.
Boeser-Nunnink, Brigitte D.
Heringa, Jaap
Schuitemaker, Hanneke
Sanders, Rogier W.
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-10-102
- URN
-
urn:nbn:de:1111-2016080730126
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- van den Kerkhof, Tom L G M.
- Feenstra, K Anton
- Euler, Zelda
- van Gils, Marit J.
- Rijsdijk, Linda W E.
- Boeser-Nunnink, Brigitte D.
- Heringa, Jaap
- Schuitemaker, Hanneke
- Sanders, Rogier W.
- SpringerLink (Online service)
Ähnliche Objekte (12)
HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
HIV-1 envelope characteristics that coincide with the development of cross-reactive neutralizing activity in HIV-1 infected patients
Cross-reactive neutralizing activity in HIV-1 infected injecting drug users
Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein
V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1
Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
HIV-1 envelope characteristics that coincide with the development of cross-reactive neutralizing activity in HIV-1 infected patients
Cross-reactive neutralizing activity in HIV-1 infected injecting drug users
Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein
V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1
Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
HIV-1 envelope characteristics that coincide with the development of cross-reactive neutralizing activity in HIV-1 infected patients
Cross-reactive neutralizing activity in HIV-1 infected injecting drug users
Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein
V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1
Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk